(Q50970036)

26 March 2018

title

Serum leptin, adiponectin, resistin and ghrelin levels in psoriatic patients treated with cyclosporin. (English)

1 reference

26 March 2018

author name string

Mustafa Ozdemir

1

1 reference

26 March 2018

Mavişe Yüksel

2

1 reference

26 March 2018

Hakkı Gökbel

3

1 reference

26 March 2018

Nilsel Okudan

4

1 reference

26 March 2018

Inci Mevlitoğlu

5

1 reference

26 March 2018

publication date

2 February 2012

1 reference

26 March 2018

The Journal of Dermatology

published in

1 reference

26 March 2018

volume

39

1 reference

26 March 2018

issue

5

1 reference

26 March 2018

page(s)

443-448

1 reference

26 March 2018

Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01497.X

Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01497.X

Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01497.X

Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01497.X

Low adipocyte-derived plasma protein adiponectin concentrations are associated with the metabolic syndrome and small dense low-density lipoprotein particles: atherosclerosis and insulin resistance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01497.X

Ghrelin and its therapeutic potential for cachectic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01497.X

Serum leptin levels, skin leptin and leptin receptor expression in psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01497.X

Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01497.X

Cyclosporine and psoriasis: 2008 National Psoriasis Foundation Consensus Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01497.X

A potential role for the nuclear factor of activated T cells family of transcriptional regulatory proteins in adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01497.X

Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01497.X

Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01497.X

Extended report: nail disease in psoriatic arthritis--clinically important, potentially treatable and often overlooked.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01497.X

Small joint involvement in psoriatic arthritis is associated with onycholysis: the Reykjavik Psoriatic Arthritis Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01497.X

Clear differences in adiponectin level and glutathione redox status revealed in obese and normal-weight patients with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01497.X

Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01497.X

Induction of hyperadiponectinemia following long-term treatment of patients with rheumatoid arthritis with infliximab (IFX), an anti-TNF-alpha antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01497.X

Lack of effect of TNFalpha blockade therapy on circulating adiponectin levels in patients with autoimmune disease: results from two independent prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01497.X

Ghrelin treatment suppresses neutrophil-dominant inflammation in airways of patients with chronic respiratory infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01497.X

Postprandial ghrelin responses are associated with the intermeal interval in time-blinded normal weight men, but not in obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01497.X

Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01497.X

Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01497.X

Calcineurin inhibitors and post-transplant weight gain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01497.X

10.1111/J.1346-8138.2011.01497.X

21 January 2018

Identifiers

DOI

1 reference

26 March 2018

release_xfedzrshbzavrmhsocvdkwyeki

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xfedzrshbzavrmhsocvdkwyeki

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

26 March 2018